Book contents
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Chapter 1 - Neurobiology of Depression
Published online by Cambridge University Press: 19 October 2021
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Summary
Depression can affect every aspect of life. A patient undergoing a major depressive episode who receives treatment with any antidepressant will often experience symptomatic improvement. However, oftentimes treatment does not reach the goal of remission (complete cessation of all symptoms of depression) until several different pharmacotherapies have been utilized, possibly in combination. Understanding the neurobiology underlying depressive symptomatology may allow clinicians the opportunity to treat the symptoms specifically, based upon brain mechanisms and the interplay among genes, circuits and symptoms. This chapter focuses on the neurobiology of depression, and offers a review of the three monoamines hypothetically linked not only to the symptoms of a major depressive episode, but also to the treatment of those symptoms.
- Type
- Chapter
- Information
- Stahl's Illustrated Antidepressants , pp. 1 - 40Publisher: Cambridge University PressPrint publication year: 2009